3. 结构
3.1 二维结构
3.2 三维结构
-1
-2
-3
25 25 0 0 0 0 0 0 0999 V2000
3.0374 -0.8958 -0.1507 O 0 0 0 0 0 0 0 0 0 0 0 0
0.6407 0.4602 0.3810 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.7117 0.2840 0.7359 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.8285 2.2182 -0.0750 N 0 0 0 0 0 0 0 0 0 0 0 0
-3.4527 -1.1652 0.1829 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.0526 -0.5251 -1.5033 N 0 0 0 0 0 0 0 0 0 0 0 0
1.8352 1.2064 -0.0150 C 0 0 0 0 0 0 0 0 0 0 0 0
0.9095 -0.8322 1.0114 C 0 0 0 0 0 0 0 0 0 0 0 0
2.7341 0.3093 -0.8576 C 0 0 0 0 0 0 0 0 0 0 0 0
1.8482 -1.6406 0.1235 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.6100 1.0020 0.3293 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.3498 -0.4211 -0.1626 C 0 0 0 0 0 0 0 0 0 0 0 0
2.3638 1.5210 0.8927 H 0 0 0 0 0 0 0 0 0 0 0 0
1.5951 2.1068 -0.5901 H 0 0 0 0 0 0 0 0 0 0 0 0
0.0033 -1.4176 1.1937 H 0 0 0 0 0 0 0 0 0 0 0 0
1.3830 -0.6483 1.9833 H 0 0 0 0 0 0 0 0 0 0 0 0
2.2642 0.0584 -1.8163 H 0 0 0 0 0 0 0 0 0 0 0 0
3.6785 0.8194 -1.0718 H 0 0 0 0 0 0 0 0 0 0 0 0
2.1413 -2.5650 0.6310 H 0 0 0 0 0 0 0 0 0 0 0 0
1.3665 -1.9162 -0.8224 H 0 0 0 0 0 0 0 0 0 0 0 0
-1.8350 2.4084 -0.0162 H 0 0 0 0 0 0 0 0 0 0 0 0
-3.7925 -1.1855 1.1383 H 0 0 0 0 0 0 0 0 0 0 0 0
-3.9568 -1.7158 -0.5034 H 0 0 0 0 0 0 0 0 0 0 0 0
-2.6127 -1.1019 -2.1217 H 0 0 0 0 0 0 0 0 0 0 0 0
-1.2661 -0.0365 -1.9172 H 0 0 0 0 0 0 0 0 0 0 0 0
1 9 1 0 0 0 0
1 10 1 0 0 0 0
2 7 1 0 0 0 0
2 8 1 0 0 0 0
2 11 1 0 0 0 0
3 11 1 0 0 0 0
3 12 2 0 0 0 0
4 11 2 0 0 0 0
4 21 1 0 0 0 0
5 12 1 0 0 0 0
5 22 1 0 0 0 0
5 23 1 0 0 0 0
6 12 1 0 0 0 0
6 24 1 0 0 0 0
6 25 1 0 0 0 0
7 9 1 0 0 0 0
7 13 1 0 0 0 0
7 14 1 0 0 0 0
8 10 1 0 0 0 0
8 15 1 0 0 0 0
8 16 1 0 0 0 0
9 17 1 0 0 0 0
9 18 1 0 0 0 0
10 19 1 0 0 0 0
10 20 1 0 0 0 0
4. 国际命名与标识
4.1 IUPAC Name
N-(diaminomethylidene)morpholine-4-carboximidamide
4.2 InChl
InChI=1S/C6H13N5O/c7-5(8)10-6(9)11-1-3-12-4-2-11/h1-4H2,(H5,7,8,9,10)
4.3 InChlKey
KJHOZAZQWVKILO-UHFFFAOYSA-N
4.4 Canonical SMILES
C1COCCN1C(=N)N=C(N)N
4.5 lsomeric SMILES
-
4.6 SDF文件
5. 波谱数据
5.1 13C核磁共振谱(13C NMR)
5.2 1H核磁共振谱(1H NMR)
5.3 质谱(MS)
5.4 红外光谱(IR)
5.5 紫外/可见光谱(UV/Vis)
6. 相关药材
7. 相关靶点
8. 相关疾病